Massachusetts Financial Services
BMRN icon

Massachusetts Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Massachusetts Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-116,564
Closed -$7.86M – 807
2019
Q3 		$7.86M Sell
116,564
-213,665
-65% -$16.5M ﹤0.01% 625
2019
Q2 		$28.3M Sell
330,229
-830,717
-72% -$71.1M 0.01% 483
2019
Q1 		$103M Buy
1,160,946
+56,500
+5% +$5.24M 0.04% 282
2018
Q4 		$94M Buy
1,104,446
+106,391
+11% +$10.1M 0.05% 271
2018
Q3 		$96.8M Buy
998,055
+29,852
+3% +$2.98M 0.04% 296
2018
Q2 		$91.2M Buy
968,203
+8,282
+0.9% +$725K 0.04% 296
2018
Q1 		$77.8M Buy
959,921
+15,213
+2% +$1.31M 0.03% 318
2017
Q4 		$84.2M Buy
944,708
+28,383
+3% +$2.47M 0.04% 314
2017
Q3 		$85.3M Sell
916,325
-28,756
-3% -$2.54M 0.04% 301
2017
Q2 		$85.8M Buy
945,081
+28,685
+3% +$2.61M 0.04% 287
2017
Q1 		$80.4M Buy
916,396
+41,176
+5% +$3.66M 0.04% 292
2016
Q4 		$72.5M Buy
875,220
+60,152
+7% +$5.17M 0.04% 301
2016
Q3 		$75.4M Buy
+815,068
New +$76.8M 0.04% 280

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Massachusetts Financial Services's BMRN Position: Q4 2019 in Review

Massachusetts Financial Services sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2019, closing a stake of 116,564 shares — an estimated $7.86M sold.

Massachusetts Financial Services first reported a position in BMRN in Q3 2016 and held it in 13 quarters. The position peaked at $103M in Q1 2019. 467 funds tracked by Wall St. Rank hold BMRN as of Q4 2019.

  • Massachusetts Financial Services reported no remaining BioMarin Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Massachusetts Financial Services sold 116,564 BioMarin Pharmaceuticals shares in Q4 2019, an estimated $7.86M.
  • Massachusetts Financial Services first reported a position in BioMarin Pharmaceuticals in Q3 2016 and held it in 13 quarters.
  • Massachusetts Financial Services's BioMarin Pharmaceuticals position peaked at $103M in Q1 2019.
  • 467 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2019.

Based on Massachusetts Financial Services's 13F filing for Q4 2019, filed 13 Feb 2020.